Citius Pharmaceuticals, Inc. (CTXR) stock
CTXRNasdaqPharmaceutical PreparationsFiscal year ends September 30
$0.53−0.01 (-1.40%)
Close on Nov 16, 2026Market cap $14.48MP/E –Yield –
Citius Pharmaceuticals total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
Citius Pharmaceuticals's total debt was $306.41M at Jun 30, 2026. For fiscal 2025 it was $300.00M, up 182178.9% from the year before.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | $300.00M | +182178.9% |
| FY2020 | Sep 30, 2020 | $164.58K | – |
Quarterly total debt
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026CQ2 2026 | Jun 30, 2026 | $306.41M | +2.1% |
| Q2 FY2026CQ1 2026 | Mar 31, 2026 | $300.00M | 0.0% |
| Q1 FY2026CQ4 2025 | Dec 31, 2025 | $300.00M | 0.0% |
| Q4 FY2025CQ3 2025 | Sep 30, 2025 | $300.00M | +182178.9% |
| Q3 FY2025CQ2 2025 | Jun 30, 2025 | $300.00M | +182178.9% |
| Q2 FY2025CQ1 2025 | Mar 31, 2025 | $300.00M | +182178.9% |
| Q1 FY2025CQ4 2024 | Dec 31, 2024 | $300.00M | +182178.9% |
| Q2 FY2021CQ1 2021 | Mar 31, 2021 | $164.58K | – |
| Q1 FY2021CQ4 2020 | Dec 31, 2020 | $164.58K | – |
| Q4 FY2020CQ3 2020 | Sep 30, 2020 | $164.58K | – |
| Q3 FY2020CQ2 2020 | Jun 30, 2020 | $164.58K | – |
See a number that looks wrong?